1. Home
  2. EVOK vs MYSZ Comparison

EVOK vs MYSZ Comparison

Compare EVOK & MYSZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EVOK
  • MYSZ
  • Stock Information
  • Founded
  • EVOK 2007
  • MYSZ 1999
  • Country
  • EVOK United States
  • MYSZ Israel
  • Employees
  • EVOK N/A
  • MYSZ N/A
  • Industry
  • EVOK Biotechnology: Pharmaceutical Preparations
  • MYSZ Computer Software: Prepackaged Software
  • Sector
  • EVOK Health Care
  • MYSZ Technology
  • Exchange
  • EVOK Nasdaq
  • MYSZ Nasdaq
  • Market Cap
  • EVOK 7.1M
  • MYSZ 8.2M
  • IPO Year
  • EVOK 2013
  • MYSZ N/A
  • Fundamental
  • Price
  • EVOK $4.99
  • MYSZ $1.76
  • Analyst Decision
  • EVOK
  • MYSZ Strong Buy
  • Analyst Count
  • EVOK 0
  • MYSZ 1
  • Target Price
  • EVOK N/A
  • MYSZ $3.00
  • AVG Volume (30 Days)
  • EVOK 9.5K
  • MYSZ 178.4K
  • Earning Date
  • EVOK 03-13-2025
  • MYSZ 03-31-2025
  • Dividend Yield
  • EVOK N/A
  • MYSZ N/A
  • EPS Growth
  • EVOK N/A
  • MYSZ N/A
  • EPS
  • EVOK N/A
  • MYSZ N/A
  • Revenue
  • EVOK $8,617,036.00
  • MYSZ $9,632,000.00
  • Revenue This Year
  • EVOK $97.35
  • MYSZ $35.62
  • Revenue Next Year
  • EVOK $99.52
  • MYSZ $12.88
  • P/E Ratio
  • EVOK N/A
  • MYSZ N/A
  • Revenue Growth
  • EVOK 100.35
  • MYSZ 43.89
  • 52 Week Low
  • EVOK $3.54
  • MYSZ $1.05
  • 52 Week High
  • EVOK $12.32
  • MYSZ $9.40
  • Technical
  • Relative Strength Index (RSI)
  • EVOK 58.60
  • MYSZ 40.63
  • Support Level
  • EVOK $4.68
  • MYSZ $1.88
  • Resistance Level
  • EVOK $5.19
  • MYSZ $2.30
  • Average True Range (ATR)
  • EVOK 0.31
  • MYSZ 0.19
  • MACD
  • EVOK 0.03
  • MYSZ -0.03
  • Stochastic Oscillator
  • EVOK 72.64
  • MYSZ 9.24

About EVOK Evoke Pharma Inc.

Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.

About MYSZ My Size Inc.

My Size Inc is a USA based technology company that focuses on the development of an application that assists the consumer to accurately take the measurements of his or her own body to fit clothing without the need to try them on using a smartphone. The purpose of the company's business is to simplify the process of clothing acquisition through the Internet and to significantly reduce the rate of returns of clothing which were acquired through the internet and which are returned to the stores because of ill-fitting. The company generates its revenue through selling products to customers, and licensing cloud-enabled software subscriptions, associated software maintenance and support.

Share on Social Networks: